NCT03136848View on ClinicalTrials.gov

The Feasibility and Safety of Normothermic ex Vivo Kidney Perfusion

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 19, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Kidney Transplantation
Interventions
DRUG

Normothermic ex-vivo kidney perfusion Solution -Toronto

"The perfusion device will circulate warmed, oxygenated blood-based perfusate (Normothermic ex-vivo kidney perfusion solution-Toronto) through the kidney."

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03136848 - The Feasibility and Safety of Normothermic ex Vivo Kidney Perfusion | Biotech Hunter | Biotech Hunter